NCT01636388: A trial that was reported late by New York Medical College
This trial has reported, although it was 1839 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01636388 |
|---|---|
| Title | A Multicenter Pilot Study of Reduced Intensity Allogeneic Stem Cell Transplantation Followed by Adoptive Cellular Immunotherapy With Donor Derived Latent Membrane Protein (LMP) Specific-CTLs in Patients With Epstein-Barr Virus (EBV)Positive Refractory or Recurrent Hodgkin Lymphoma |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 31, 2013 |
| Completion date | June 30, 2017 |
| Required reporting date | June 30, 2018, midnight |
| Actual reporting date | July 13, 2023 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 1839 |